680 filings
Page 13 of 34
6-K
dyw30cgv vky
11 May 20
Current report (foreign)
7:00am
6-K
604s5eh0oka2txw
8 May 20
Current report (foreign)
7:00am
6-K
zt9si3hxa2
5 May 20
Current report (foreign)
7:00am
6-K
k6f9c lj5
4 May 20
Current report (foreign)
9:00am
6-K
obm8fcnc oc
28 Apr 20
RedHill Biopharma Strengthens Coverage for Talicia® with Preferred Brand Position on Prime Therapeutics NetResults™ National Formulary
7:00am
6-K
alljy aiu
27 Apr 20
Current report (foreign)
7:00am
6-K
5bcdy9r3
20 Apr 20
RedHill Biopharma Announces Agreement with NIAID to Evaluate RHB-107 Against COVID-19
9:00am
6-K
fy3sfo6d 509b
20 Apr 20
Current report (foreign)
7:00am
6-K
7d59wldlrv
17 Apr 20
Current report (foreign)
1:41pm
6-K
bjvv0b0 pe
17 Apr 20
Additional Update on COVID-19 Compassionate Use with Opaganib in Israel Provided by RedHill Biopharma
9:53am
6-K
zmdsw59glqyal
13 Apr 20
RedHill Biopharma Provides Initial Update from its Opaganib COVID-19 Compassionate Use Program in Israel
7:00am
6-K
6nmdoyj
6 Apr 20
Current report (foreign)
8:00am
6-K
snte9 sgy
6 Apr 20
Current report (foreign)
6:05am
6-K
iswdgv
2 Apr 20
RedHill Biopharma Completes Acquisition of Movantik® from AstraZeneca
8:30am
6-K
njrb999iw70r
1 Apr 20
Current report (foreign)
8:00am
6-K
b6lhiymkolgmnyhb
26 Mar 20
Current report (foreign)
8:00am
6-K
5c3ncw
25 Mar 20
Current report (foreign)
7:00am
6-K
zwizf8w
23 Mar 20
Current report (foreign)
8:00am
6-K
h6v en9ka8f
13 Mar 20
RedHill recently launched Talicia® in the U.S., calling on gastroenterologists, primary care physicians and other healthcare providers
7:00am
6-K
zpzw2y65hzfh6z de
11 Mar 20
Current report (foreign)
7:00am